On ECHEMI
Home > Drugs > Vertebral tuberculosis
Vertebral tuberculosis
Vertebral tuberculosis refers to lesions limited to the pedicles, lamina, spinous processes or transverse processes, rather than lesions secondary to vertebral tuberculosis extending to the pedicles, transverse processes or upper and lower articular processes. This disease is relatively rare, accounting for 0.8% to 1% of spinal tuberculosis. In another group of 10,531 cases of spinal tuberculosis, there were 45 cases, accounting for 2.3%. Among the 3,139 cases of spinal tuberculosis in the Beijing Tuberculosis Prevention and Control Institute, only 17 cases, accounting for 0.4%. The reason for the low incidence rate is that some scholars believe that the vertebral arch arterioles have abundant anastomoses, are not prone to embolism, are not weight-bearing, have little local cancellous bone, and are rich in surrounding muscles.
  • Site of disease:

    spine
  • Infectious :

    Contagious
  • Frequent population:

    More common in people with tuberculosis
  • Related symptoms:

    Spinal cord compression abscess vertebral tuberculosis paraplegia sensory impairment
  • Concurrent disease:

Related Drugs
Rifampicin Capsules
Indication: 1 This product is used in combination with other anti-tuberculosis drugs for the initial and retreatment of various tuberculosis diseases, including the treatment of tuberculous meningitis. 2 This product is used in combination with other drugs to treat leprosy and non-tuberculous mycobacterial infections. 3 This product can be used in combination with vancomycin (intravenous) for severe infections caused by methicillin-resistant Staphylococci. The combination of rifampicin and erythromycin is used for severe Legionella infections. 4 It is used for asymptomatic carriers of Neisseria meningitidis to eliminate Neisseria meningitidis in the nasopharynx; but it is not suitable for the treatment of Neisseria meningitidis infections.
Manufacturer:

Sinopharm Medicine Holding Xingsha Pharmaceutical (Xiamen) Co., Ltd.

Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.